Search Results

You searched for : NEJM  

DATA PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE SHOWS PFIZER’S TOFACITINIB MEETS PRIMARY ENDPOINT IN BRAZILIAN STUDY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-...
Jun 17

South African variant of Covid-19 could significantly reduce vaccine protection, says Pfizer

Pfizer Inc/BioNTech said according to a laboratory study, the South African variant of the coronavirus may reduce antibody protection from their vaccine by two-...
Feb 18

Enhertu approved in the US for the treatment of patients with previously treated HER2-positive advanced gastric cancer

In the US, gastric cancer is most frequently diagnosed in the advanced stage, with only approximately 5% of patients surviving beyond five years....
Jan 18

Farxiga granted Priority Review in the US for the treatment of patients with chronic kidney disease

Farxiga could become the first SGLT2 inhibitor approved to treat patients with chronic kidney disease, with and without type-2 diabetes...
Jan 06

Tagrisso approved in the US for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer

Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%...
Dec 21

ABBOTT STRENGTHENS STRUCTURAL HEART PORTFOLIO WITH NEW CLIP DELIVERY SYSTEM

Abbott has launched its clip delivery system, a minimally invasive heart valve repair device to treat mitral regurgitation in India. ...
Dec 18

AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer’s disease met its primary endpoint

MASITINIB DEMONSTRATED SIGNIFICANT EFFECT ON BOTH COGNITION, MEASURED WITH ADAS-COG, AND DAILY ACTIVITY, MEASURED WITH ADCS-ADL...
Dec 16

Trixeo Aerosphere approved in the EU for maintenance treatment of COPD

COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ...
Dec 14

Trastuzumab deruxtecan recommended for approval in the EU by CHMP for HER2-positive metastatic breast cancer

The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year....
Dec 14

RESULTS FROM PHASE 3 CROWN TRIAL OF PFIZER’S LORBRENA IN PREVIOUSLY UNTREATED ALK-POSITIVE LUNG CANCER PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE

...
Nov 19

ABBOTT STRENGTHENS STRUCTURAL HEART PORTFOLIO WITH NEW CLIP DELIVERY SYSTEM FOR NON-INVASIVE TREATMENT OF LEAKY MITRAL VALVES

Clinical evidence for this device demonstrates safety and efficacy for people suffering from mitral regurgitation...
Nov 18

Forxiga recommended for approval in the EU by CHMP for heart failure

If approved, Forxiga would become the first SGLT2 inhibitor indicated for heart failure with reduced ejection fraction in patients with and without type-2 diabetes...
Oct 19

Antibodies may not guarantee protection from COVID-19, say scientists

Scientists skeptic about antibodies theory and plasma therapy...
Sep 08

Regeneron announces FDA accepts evinacumab BLA for priority review as treatment for patients with HoFH

The FDA granted evinacumab breakthrough therapy designation in 2017 for the treatment of hypercholesterolemia in patients with HoFH...
Aug 13

Observational study of Hydroxychloroquine in hospitalized Covid-19 patients

Hydroxychloroquine has been broadly controlled to patients with Covid-19 without strong proof supporting its utilization...
May 26

Area9 and AACC Release COVID-19 Learning Module

Adaptive Learning Course Now Available at No Cost to Health Professionals...
Mar 11

Sequencers Have Left UK for China, to Support Rapid, Near-sample Coronavirus Sequencing for Outbreak Surveillance

Sequencers from UK to reach China to help quick surveillance of Coronavirus...
Feb 01

17 Matching result(s) found!

-Advertisements-




Trending Now

Navigating Legal Waters: Covishield's Side Effects Prompt Legal Battle from Parents May 02, 2024
Mumps Resurgence in India: Understanding the Recent Outbreak and Prevention StrategiesMay 02, 2024
Genomic Insights Unveiled: Illumina and Garvan Institute Collaborate to Map Disease FingerprintsMay 02, 2024
10 key reasons why social media presence is crucial in healthcareApril 30, 2024
Shocking Research Expose the Link Between Traffic Noise and Cardiovascular HealthApril 30, 2024
How Are We Awaken After Anaesthesia: Study Reveals Reveals Brain's Protective MechanismApril 30, 2024
Transformative Parenting Guide "Awakening Parenthood Vol-1" by Rommal Surana Debuts to AcclaimApril 29, 2024
Sleep Quality and Its Influence on Chronic Kidney DiseaseApril 29, 2024
Medulance is Official Emergency Services Partner of Delhi Capitals for a second time in IPL 2024April 29, 2024
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal VaccineApril 29, 2024
Moving Towards Better Mental Health: Know The Impact of Low-intensity Workout For Your Mental Well-being April 29, 2024
Exploring Mortality Risks for Lesbian and Bisexual Women: Key Findings from a Comprehensive Research EffortApril 29, 2024
Implications of Alcohol Intake During Pregnancy on Fetal Development: New Study Reveals Subtle ChangesApril 29, 2024
Indian Air Force's Night Vision Rescue: Soldier’s Life Saved in High-Stakes AirliftApril 29, 2024
Now You Can Also Buy Insurance For Your Parents Aged Above 65 years: IRDAI Lifts Age Cap for Health Insurance Expanding Healthcare AccessApril 29, 2024
Ensuring Infection Control: Central Government Hospitals Implement New Safety MeasuresApril 29, 2024
9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach RecognisedApril 27, 2024
Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024